Apr 24, 2017 7:00am EDT Matinas BioPharma Presents Positive Preclinical Data of Orally Available DNA Vaccines at the 27th Annual European Congress of Clinical Microbiology and Infectious Diseases
Apr 18, 2017 7:01am EDT Matinas BioPharma Appoints Dominick DiPaolo as Senior Vice President of Quality and Regulatory Compliance
Apr 03, 2017 7:06am EDT Matinas BioPharma Reports 2016 Financial Results and Provides Corporate Update
Mar 30, 2017 7:05am EDT Matinas BioPharma Appoints Eric J. Ende, M.B.A, M.D. to its Board of Directors
Mar 27, 2017 7:35am EDT Matinas BioPharma Reports Positive Topline Data from Phase 1 Study of MAT2501
Mar 08, 2017 8:01am EST Matinas BioPharma Announces Positive Preclinical Efficacy Results of MAT2501 in an In Vitro Model of Mycobacterium abscessus Infection
Mar 06, 2017 8:05am EST Matinas BioPharma and NIH/NIAID Initiate Open-Label Extension to Phase 2a Study of MAT2203 in Chronic Mucocutaneous Candidiasis
